JPS6327413A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS6327413A JPS6327413A JP61172450A JP17245086A JPS6327413A JP S6327413 A JPS6327413 A JP S6327413A JP 61172450 A JP61172450 A JP 61172450A JP 17245086 A JP17245086 A JP 17245086A JP S6327413 A JPS6327413 A JP S6327413A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- filtrate
- endomyces
- culture
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 239000000706 filtrate Substances 0.000 claims abstract description 45
- 241000178951 Endomyces Species 0.000 claims abstract description 18
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 9
- 241000159580 Magnusiomyces magnusii Species 0.000 claims abstract description 6
- 229920000642 polymer Polymers 0.000 claims abstract 2
- 241000894006 Bacteria Species 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 10
- 239000012141 concentrate Substances 0.000 abstract description 6
- 238000001914 filtration Methods 0.000 abstract description 5
- 239000003755 preservative agent Substances 0.000 abstract description 5
- 230000002335 preservative effect Effects 0.000 abstract description 5
- 241000233866 Fungi Species 0.000 abstract description 4
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000003780 keratinization Effects 0.000 abstract description 2
- 239000003906 humectant Substances 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 238000007788 roughening Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 45
- 230000003020 moisturizing effect Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 208000001840 Dandruff Diseases 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 7
- 230000007803 itching Effects 0.000 description 7
- 150000007524 organic acids Chemical class 0.000 description 7
- 235000005985 organic acids Nutrition 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 244000168141 Geotrichum candidum Species 0.000 description 2
- 235000017388 Geotrichum candidum Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000212749 Zesius chrysomallus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000159512 Geotrichum Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- -1 Polyoxyethylene cetyl ether Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000583281 Sugiura Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、皮膚の保湿に有効な新しい皮膚化粧料(医薬
部外品たる薬用化粧料及び医薬品たる外用皮膚用剤を含
む。以下同じ)、殊にエンドミセス属に属する菌の培養
ろ液を有効成分として含有する皮膚化粧料に関する。更
に詳しくは、本発明はエンドミセス属に属する菌の培養
ろ液中に含有される種々のアミノ酸、ペプチド、蛋白質
、糖類、有機酸、無機塩等の総合作用により、皮膚の角
質層部分の水分を正常に保持することによって、膚あれ
、皮膚の角化等を防ぎ、皮膚の柔軟性を維持することに
有効な微生物製剤に係わる。Detailed Description of the Invention (Field of Industrial Application) The present invention is a new skin cosmetic product effective for moisturizing the skin (including medicinal cosmetics as quasi-drugs and external skin preparations as pharmaceuticals; the same applies hereinafter). In particular, the present invention relates to a skin cosmetic containing a culture filtrate of a bacterium belonging to the genus Endomyces as an active ingredient. More specifically, the present invention improves the moisture content of the stratum corneum of the skin through the comprehensive action of various amino acids, peptides, proteins, sugars, organic acids, inorganic salts, etc. contained in the culture filtrate of bacteria belonging to the genus Endomyces. The present invention relates to microbial preparations that are effective in preventing skin roughness, skin keratinization, etc., and maintaining skin flexibility by maintaining the skin in a normal state.
(従来の技術)
化粧料は近年、皮膚の健康維持又は改善といったいわゆ
る有用性が重要視されてきており、その技術的な裏付け
を得る研究が盛んに行われている。(Prior Art) In recent years, importance has been placed on the so-called usefulness of cosmetics, such as maintaining or improving skin health, and research to obtain technical support for this has been actively conducted.
とりわけ、皮膚の角質層部分の保湿機構は、皮膚の健康
維持又は改善に対して極めて重要な役割を演じている。In particular, the moisturizing mechanism of the stratum corneum of the skin plays an extremely important role in maintaining or improving skin health.
健康な皮膚の角質層には通常10〜30%の水分が含有
されており、潤いとか柔軟性が維持されているが、種々
の原因で10%以下になると、乾燥肌となり、柔軟性と
か弾力性が失われ、ひいては肌あれ、さめ肌、ヒビ、ア
カギレ、フケ、カユミ等のスキントラブルが発生する。Normally, the stratum corneum of healthy skin contains 10 to 30% water, which maintains moisture and flexibility, but when it becomes less than 10% due to various reasons, the skin becomes dry and loses its flexibility and elasticity. This leads to loss of sexiness, which in turn leads to skin problems such as rough skin, rough skin, cracks, red spots, dandruff, and itching.
さらには、それがシミ、小じわ等に進展するといわれて
いる・生体皮膚の保湿には、自然保湿因子(Natur
al Moisturizing Factor+
N、M、F、)と呼ばれるアミノ酸類、ピロリドンカル
ボン酸、乳酸塩・尿素、無機塩等の吸湿性、保湿性の高
い親水性の成分とそれらの流出を防止し、水分の移動を
制御している脂質成分が重要な役割を果していることが
知られている。Furthermore, it is said that this can develop into age spots, fine wrinkles, etc. - Natural moisturizing factors (Natural moisturizing factors) are needed to moisturize living skin.
al Moisturizing Factor+
Hydrophilic components with high hygroscopicity and moisturizing properties such as amino acids (N, M, F,), pyrrolidone carboxylic acid, lactate, urea, and inorganic salts prevent their leakage and control the movement of moisture. It is known that the lipid components in the body play an important role.
従来から化粧料に、皮膚の保湿を目的としてグリセリン
、プロピレングリコール、ジプロピレングリコール、1
.3−ブチレングリコール、ポリエチレングリコール、
多価アルコール、ピロリドンカルボン酸、糖類、アミノ
酸等の保湿剤が多用されている。更に近年は、自然保湿
因子により近づける処方系を開発すべく種々の工夫がな
されているが、自然保湿因子には未知成分が数多く存在
することとかその構成成分が複雑多岐にわたりかつ構成
比率が明らかでない等の理由から、真に効果のあるもの
が得られなかった。又処方化に当たっては、これらの成
分を個々に配合する必要があるのみならず、あまり複雑
な処方系にすると沈澱を生じる等製品の安定性を保つ上
でも種々の問題があった。Glycerin, propylene glycol, dipropylene glycol, etc. have traditionally been used in cosmetics for the purpose of moisturizing the skin.
.. 3-butylene glycol, polyethylene glycol,
Moisturizing agents such as polyhydric alcohol, pyrrolidone carboxylic acid, sugars, and amino acids are often used. Furthermore, in recent years, various efforts have been made to develop formulation systems that more closely approximate natural moisturizing factors; however, there are many unknown components of natural moisturizing factors, and their constituent components are complex and diverse, and their composition ratios are unclear. For these reasons, nothing truly effective could be obtained. Furthermore, in formulation, it is not only necessary to mix these components individually, but also there are various problems in maintaining the stability of the product, such as the formation of precipitates if the formulation is too complicated.
(発明が解決しようとする問題点)
本発明は、優れた保湿効果を有する化粧料として、望ま
しく且つ物理化学的に安定で、安全な新規の素材を提供
することを目的とする。(Problems to be Solved by the Invention) An object of the present invention is to provide a novel material that is desirable, physicochemically stable, and safe as a cosmetic having an excellent moisturizing effect.
(問題点を解決するための手段)
本発明者らは、化粧料となりうる物質を広く自然界に求
め、特に微生物に注目した。そして、多種の微生物及び
その培養条件等を詳細に検討した結果、エンドミセス属
に属する菌の培養ろ液が、優れた保湿効果を有する化粧
料として要求される条件を全て満足するものであること
を見い出し、本発明を完成するに至った。(Means for Solving the Problems) The present inventors searched widely for substances that can be used as cosmetics in nature, and particularly focused on microorganisms. As a result of a detailed study of various types of microorganisms and their culture conditions, we found that the culture filtrate of bacteria belonging to the genus Endomyces satisfies all the conditions required for a cosmetic product with excellent moisturizing effects. They discovered this and completed the present invention.
本発明の培養に使用されるエンドミセス属に属する菌は
、エンドミセス・マグヌシ(Endomycesmag
nusii) 、エンドミセス・ゲオトリカム(End
o−myces geotrichum) 、エンドミ
セス・ベージ−(Endomyces veessii
)等いずれを使用してもよく、培養ろ液が、優れた保
湿効果を有し、肌あれ、皮膚の角化症等に対して予防及
び治療効果を有するものであれば、その菌種は特に限定
されない。The bacteria belonging to the genus Endomyces used for the culture of the present invention are Endomyces magnusii (Endomyces magnus).
nusii), Endomyces geotrichum (End
o-myces geotrichum), Endomyces vessii
) etc. may be used, as long as the culture filtrate has an excellent moisturizing effect and has preventive and therapeutic effects on rough skin, skin keratosis, etc. Not particularly limited.
培養ろ液に白濁を生じにくいこと及び芳香性の面から、
より好ましくは、エンドミセス・マグヌシが使用され得
る。使用される菌株は、例えば公知の微生物であるエン
ドミセス・マグヌシIFO4600(Endomyce
s magnusii IFO4600)が分譲を受
けて使用され得るが、特に限定する必要はなく、自然界
から分離したもの、その人工的又は自然的変異株を使用
することができる。From the viewpoint of not causing cloudiness in the culture filtrate and having aromatic properties,
More preferably, Endomyces magnusii may be used. The strain used is, for example, Endomyces magnusii IFO4600, which is a known microorganism.
S. magnusii IFO4600) can be used after receiving distribution, but there is no need to be particularly limited, and those isolated from the natural world and artificial or natural mutants thereof can be used.
エンドミセス属に属する菌の培養方法は、特に限定され
るものではなく、この発明の実施に使用する菌が良好に
増殖する条件であればいかなる条件でもかまわない。使
用する窒素源としては、使用するエンドミセス属に属す
る菌が資化できるものであれば何でもよく、例えばポリ
ペプトン、スキムミルク、酵母エキス、麦芽エキス、ア
ミノ酸等の有機窒素源を単独で、又は組み合わせて使用
することができる。炭素源としては、使用するエンドミ
セス属に属する菌で資化できるものであれば何でもよく
、例えばグルコース、ガラクトース、シェークロース、
グリセリン等が使用できる。又培地に依存して必要があ
れば、マグネシウム塩、ナトリウム塩、カリウム塩等の
無機塩類、ビタミン類、アミノ酸類又はこれらを豊富に
含有する物質を添加することができる。前記の資化物質
の濃度は、種類により異なるが0.1g/j!〜100
g/2とし、培養温度は20℃〜35℃の範囲であれば
よい。培養中の培地のpIiは3.5〜8.5の範囲と
する。The method for culturing the bacteria belonging to the genus Endomyces is not particularly limited, and any conditions may be used as long as the bacteria used in the practice of this invention can grow well. The nitrogen source to be used may be anything as long as it can be assimilated by the bacteria belonging to the genus Endomyces. For example, organic nitrogen sources such as polypeptone, skim milk, yeast extract, malt extract, and amino acids may be used alone or in combination. can be used. The carbon source may be anything as long as it can be assimilated by the bacteria belonging to the genus Endomyces used, such as glucose, galactose, shakerose, etc.
Glycerin etc. can be used. If necessary depending on the medium, inorganic salts such as magnesium salts, sodium salts, and potassium salts, vitamins, amino acids, or substances rich in these may be added. The concentration of the above-mentioned assimilation substances varies depending on the type, but it is 0.1 g/j! ~100
g/2, and the culture temperature may be in the range of 20°C to 35°C. The pIi of the medium during culture is in the range of 3.5 to 8.5.
培養は静置培養、振とう培養又は通気攪拌培養等の方法
により行う。培養条件によっても異なるが2〜7日間培
養後、除菌ろ過することによって得ることができる。こ
の際、ウルトラフィルトレージョンによる限外ろ過を行
い、培養ろ液から分子M 13.000以上の高分子物
質を除去した後、メンブレン・フィルターにてろ過する
ことにより、アレルギーの可能性を無くした極めて安全
性の高い化粧料を得ることができる。ここで使用する限
外ろ過膜は分子量13,000以上のものを分画できる
ものであればいかなるものでもよい。こうして得られた
培養無菌ろ過液を、化粧料として使用するに当たっては
、培養無菌ろ過液又はその濃縮物がそのままでも使用し
得るが、防腐剤等を添加してその安全性を高めることが
望ましい。又通常の化粧水、乳液、クリーム等に配合し
て使用することもできる。こうして得られた培養無菌ろ
過液は、各種アミノ酸、有機酸、ペプクイド、可溶性蛋
白、アルコール等を含有しており、又特に特徴付けられ
る点としては、アップル、パインアップル様のフルーツ
エステル香を生成することである。Cultivation is carried out by methods such as static culture, shaking culture, or aerated agitation culture. Although it varies depending on the culture conditions, it can be obtained by sterilizing and filtering after culturing for 2 to 7 days. At this time, ultrafiltration was performed using Ultrafiltration to remove polymeric substances with a molecular M of 13,000 or more from the culture filtrate, and the possibility of allergies was eliminated by filtration with a membrane filter. Cosmetics with extremely high safety can be obtained. The ultrafiltration membrane used here may be of any type as long as it can fractionate substances with a molecular weight of 13,000 or more. When using the cultured sterile filtrate thus obtained as a cosmetic, the cultured sterile filtrate or its concentrate can be used as is, but it is desirable to add a preservative or the like to increase its safety. It can also be used by blending it into ordinary lotions, emulsions, creams, etc. The cultured sterile filtrate thus obtained contains various amino acids, organic acids, pepquids, soluble proteins, alcohol, etc., and is particularly characterized by the fact that it produces a fruit ester aroma similar to apple and pineapple. That's true.
次にエンドミセス属に属する菌の培養無菌ろ液の分析例
について示す。例示された培養ろ液は、実施例1の(A
)、(B)、(C)及び(D)で得られた培養ろ液であ
る。Next, an example of analysis of a sterile cultured filtrate of bacteria belonging to the genus Endomyces will be shown. The exemplified culture filtrate is (A
), (B), (C) and (D).
まず一般的な分析値を第−表に示す。First, general analytical values are shown in Table 1.
(以下余白)
第−表
次に、当該培養ろ液が有する保湿効果と関係が深いと考
えられるアミノ酸、有機酸、可溶性蛋白について定性的
、定量的な成分分析結果を以下に示す。(Left space below) Table 1 Next, qualitative and quantitative component analysis results are shown below for amino acids, organic acids, and soluble proteins that are considered to be closely related to the moisturizing effect of the culture filtrate.
アミノ酸
第二表に示すとおり皮膚の保湿に必要とされる自然保湿
因子成分の一つであるアミノ酸が多種類台まれているこ
とが判る。As shown in the second amino acid table, it can be seen that there are many types of amino acids, which are one of the natural moisturizing factor components required for moisturizing the skin.
似下余白)
有機酸
第−図に示すとおり自然保湿因子の成分とされているク
エン酸、乳酸が確認されるが、それ等以外にも酢酸、フ
マール酸、郵酸、イソ酪酸、イソ吉草酸及び多種類の未
知有機酸のピークが認められる。 ・
可溶性蛋白(ペプタイド)
可溶性蛋白の分子量分布は第二図に示すとおりである。Organic Acids - As shown in the figure, citric acid and lactic acid, which are considered to be components of natural moisturizing factors, have been confirmed, but in addition to these, acetic acid, fumaric acid, lactic acid, isobutyric acid, and isovaleric acid are also found. and peaks of various unknown organic acids are observed. - Soluble protein (peptide) The molecular weight distribution of soluble protein is shown in Figure 2.
これ等の可溶性蛋白も皮膚の保湿機構に関与する可能性
は、当然予測されるところであるが、酵素作用をはじめ
として何らかの生理活性作用を有する可能性も否定でき
ない。しかし、この−点に関しては未だ明らかにし得な
い。Although it is naturally predicted that these soluble proteins may be involved in the skin moisturizing mechanism, the possibility that they have some kind of physiologically active action including enzymatic action cannot be denied. However, this point cannot be clarified yet.
又、当該培養ろ液の有するフルーツエステル芳香につい
ては、その成分として酢酸イソブチル、酢酸エチル、2
−メチルプロピオン酸、2−及び3−メチル酪酸等が確
認さている。In addition, regarding the fruit ester aroma possessed by the culture filtrate, its components include isobutyl acetate, ethyl acetate, and
-Methylpropionic acid, 2- and 3-methylbutyric acid, etc. have been confirmed.
(実施例及び実験例)
次に本発明について実施例及び実験例をもとに詳しく説
明する。(Examples and Experimental Examples) Next, the present invention will be described in detail based on Examples and Experimental Examples.
実施例1 (培養無菌ろ液の調整)
(A)グルコース3g/11スキムミルク5g/β、酵
母エキス0.5g /βを含む培地をpH6,0に調整
した後、 115℃、30分加熱滅菌し、エンドミセス
・マグヌシIFO4600を接種し、25℃で4日間静
置培養した。この培養物を除菌ろ過した後、ウルトラフ
ィルトレージョンによる限外ろ過を行い、分子量13,
000以上の高分子物質を除去した後、メンブランフィ
ルタ−にてろ過することによって無菌ろ液(A)を得た
。Example 1 (Preparation of sterile culture filtrate) (A) A medium containing 3 g of glucose/5 g of 11 skim milk/β and 0.5 g of yeast extract/β was adjusted to pH 6.0 and then heat sterilized at 115° C. for 30 minutes. , Endomyces magnusii IFO4600 was inoculated and statically cultured at 25°C for 4 days. After sterilizing and filtering this culture, ultrafiltration was performed using Ultrafiltration, and the molecular weight was 13.
After removing 000 or more polymeric substances, a sterile filtrate (A) was obtained by filtration with a membrane filter.
(B)種菌として、自然界より分離したエンドミセス・
マグヌシを用いて、前記(A)と同様の方法で培養を行
い、培養無菌ろ液(B)を得た。(B) As a seed fungus, Endomyces isolated from nature
Cultivation was carried out in the same manner as in (A) using M. magnusi to obtain a sterile culture filtrate (B).
(C)種菌として、エンドミセス・ゲオトリカムIFO
9541を用いて、前記(A)と同様の方法で培養を行
い、培養無菌ろ液(C)を得た。(C) Endomyces geotrichum IFO as the inoculum
Using 9541, culture was carried out in the same manner as in (A) above to obtain a culture sterile filtrate (C).
(D)種菌として、エンドミセス・ベージ−IPO11
12を用いて、前記(A)と同様の方法で培養を行い、
培養無菌ろ液(D)を得た。(D) As a seed fungus, Endomyces beige-IPO11
12 and cultured in the same manner as in (A) above,
A culture sterile filtrate (D) was obtained.
保湿効果に関する実験
上記の実施例1の(A)、(B)、CC”)及び(D)
で得たエンドミセス属に属する各種の菌の培養無菌ろ液
を人前腕内側に塗布し、角質層の水分含有量及びその経
時変化を田土の方法〔田土へ部1日皮会誌、飢(51,
445(1980) )により試験した結果を第三図に
示す。但し、対照として生理食塩水及び化粧品の保湿剤
としてよく使用される尿素の2%水溶液を使用した。本
発明の培養無菌ろ液は優れた水分保持能力を有すること
がわかる。Experiment regarding moisturizing effect (A), (B), CC'') and (D) of Example 1 above
The cultured sterile filtrate of various bacteria belonging to the genus Endomyces obtained in ,
445 (1980)) are shown in Figure 3. However, as controls, physiological saline and a 2% aqueous solution of urea, which is often used as a moisturizing agent in cosmetics, were used. It can be seen that the culture sterile filtrate of the present invention has an excellent water retention ability.
実施例2 (化粧水)
処方 重量%
培養無菌ろ液(A )90.0
エタノール 5.0保存剤
0.2楕製氷
残部
得られた化粧水の肌あれ等に対する効果を次のとおり試
験した。Example 2 (Lotion) Prescription Weight % Cultured sterile filtrate (A) 90.0 Ethanol 5.0 Preservative
0.2 oval ice cube
The effect of the remaining lotion on rough skin was tested as follows.
(1)被験者
肌あれ :自他覚的に肌あれ症状のある男子7名(28
才〜41才)女子23名 (22才〜56才)さめ肌
:さめ肌症状のある男子3名(21才〜27才)女子9
名(11才〜32才)
アカギレ:アカギレ症状のある男子8名(7オ〜29才
)女子7名 (18才〜33才)(2)試験方法
被験者に、毎日朝夕2薗、温湯で洗顔後に化粧水を塗ら
せ、14日後にその症状の改善効果を評価した。(1) Subjects' skin roughness: 7 boys (28
23 women (22 to 56 years old) with smooth skin
: 3 boys (21-27 years old) and 9 girls with dry skin symptoms
(11 to 32 years old) Akagiri: 8 boys (7 to 29 years old) and 7 women (18 to 33 years old) with symptoms of red rash (2) Test method Subjects washed their faces with warm water twice a day, morning and evening. Afterward, the subjects were asked to apply a lotion, and 14 days later, the improvement effect on the symptoms was evaluated.
(3)評価 各症状を程度により次の通り区分した。(3) Evaluation Each symptom was classified as follows according to its severity.
肌あれ
1:皮膚表面がカサカサしており、角辺が剥がれやすく
、常時白い粉をふいており、爪先でひっかくと、その線
にそって角辺が容易に剥がれ落ちる。Skin roughness 1: The surface of the skin is dry, the edges tend to peel off, and the skin is constantly covered with white powder, and when scratched with the tip of the toe, the edges easily peel off along the lines.
2:皮膚表面がカサカサしており、角辺が剥がれて僅か
に白い粉をふいている。2: The skin surface is dry, the corners are peeled off and a slight white powder is observed.
3:皮膚表面がカサカサしており、荒れてはいるが角辺
が剥がれて白い粉をふ(ことはない。3: The skin surface is dry and rough, but the edges do not peel off and give off white powder.
4:皮膚表面にうるおいがあり、すべすべしている。4: The skin surface is moist and smooth.
さめ肌
1:皮膚表面が乾燥しており、皮膚全面に魚の鱗状の鮮
明な裂は目を認める。Shark skin 1: The skin surface is dry, and clear fissures in the shape of fish scales can be seen all over the skin.
2:皮膚表面が乾燥しており、皮膚全面に魚の鱗状の裂
は目を認めるが、それほど鮮明ではない。2: The skin surface is dry, and fish scale-like fissures can be seen all over the skin, but they are not very clear.
3:皮膚表面が僅かに乾燥しており、部分的に不鮮明な
魚の鱗状の裂は目を認める。3: The skin surface is slightly dry, and partially indistinct fish scale-like fissures are visible.
4:皮膚表面にうるおいがあり、魚の鱗状の裂は目は認
められない。4: There is moisture on the skin surface, and no fish scale-like fissures are observed in the eyes.
アカギレ ゛
1:皮膚表面がカサカサしており、切り渦状の裂は目が
多数法められる。Akagiri ゛1: The skin surface is dry, and there are many incisions and spiral fissures.
2:皮膚表面がカサカサしており、切り渦状の裂は目が
所々に認められる。2: The skin surface is dry, and spiral cracks are observed in some places.
3:皮膚表面が僅かにカサカサしており、小さな渦状の
ササフレが僅かに認められる。3: The skin surface is slightly dry, and small spiral sassafres are slightly observed.
4:皮膚表面にうるおいがあり、ササフレ状の傷は認め
られない。4: The skin surface is moist and no sassafre-like scars are observed.
この症状の区分に従い次の様に評価した。The symptoms were evaluated as follows according to the classification of symptoms.
有 効:症状が1から3.4に、及び2から4に改善
されたもの。Effective: Symptoms improved from 1 to 3.4 and from 2 to 4.
やや有効:症状が1から2に、2から3に及び3から4
に改善されたもの。Moderately effective: Symptoms 1 to 2, 2 to 3, and 3 to 4
improved on.
無 効:症状にさほど変化が無いか又は悪化したもの
。Ineffective: Symptoms have not changed significantly or have worsened.
評価結果を第三表に示す。The evaluation results are shown in Table 3.
(以下余白)
第三表
実施例3 (クリーム)
処方 重量%
ステアリン酸 2.0ステアリ
ルアルコール 7.0スクワラン
5.0還元ラノリン
2.0オクチルドデカノール 6
.0ポリオキシエチレンセチル
エーテル(25E、O,) 3.0親油型
モノステアリン酸グリセリン 2.0防腐剤
0・3酸化防止剤、
0.1培養無菌ろ液(A )60.0
精製水 残部
得られたクリームの肌あれ等に対する効果を実施例3に
おけると同様に試験した。但し被験者数は次のとおりで
ある。(Margin below) Table 3 Example 3 (Cream) Formula Weight % Stearic acid 2.0 Stearyl alcohol 7.0 Squalane
5.0 reduced lanolin
2.0 octyldodecanol 6
.. 0 Polyoxyethylene cetyl ether (25E, O,) 3.0 Lipophilic glycerin monostearate 2.0 Preservative
0.3 antioxidant,
0.1 Culture sterile filtrate (A) 60.0 Purified water Remaining part The effect of the obtained cream on rough skin etc. was tested in the same manner as in Example 3. However, the number of subjects is as follows.
肌あれ :男子3名(36オ〜42才)女子7名(23
才〜52才)
さめ肌 :女子10名(16オ〜39才)アカギレ:男
子4名(19才〜33才)女子6名(32才〜57才)
評価結果を第四表に示す。Skin irritation: 3 boys (36-42 years old), 7 girls (23 years old)
(Ages 52 to 52) Same skin: 10 females (16 to 39 years old) Dark skin: 4 males (19 to 33 years old), 6 females (32 to 57 years old) The evaluation results are shown in Table 4.
(以下余白)
第四表
実施例4(ヘアートニック)
処方 重量%
培養無菌ろ液(A) 60.0エタノー
ル 27.0防腐剤
0.1精製水 残
部
得られたヘアートニックのフケ、カユミに対する効果を
次のとおり試験した。(Left below) Table 4 Example 4 (Hair Tonic) Prescription Weight % Sterile culture filtrate (A) 60.0 Ethanol 27.0 Preservative
0.1 Purified water Remaining part The effect of the obtained hair tonic on dandruff and itching was tested as follows.
(1)被験者
激しくフケ、カユミを訴える男子20名(22才〜43
才)
(2)試験方法
被験者に、毎日朝夕2回、ヘアートニックを塗布させ、
14日後にその改善効果について自己評価させた。(1) Subjects: 20 boys (22 to 43 years old) complaining of severe dandruff and itching.
(2) Test method Subjects were asked to apply hair tonic twice a day in the morning and evening.
After 14 days, the subjects were asked to self-evaluate the improvement effect.
(3)評価 自己申告による効果を次のとおり区分した。(3) Evaluation Self-reported effects were classified as follows.
有 効:フケ、カユミが殆ど或は全く無くなった。Effective: Dandruff and itching are almost completely gone.
やや有効:フケ、カユミはまだ少しあるがよく効いた。Slightly effective: There is still some dandruff and itching, but it worked well.
無 効:フケ、カユミに対して殆ど或は全く効果がな
かった。Ineffective: There was little or no effect on dandruff and itching.
評価結果を第五表に示す。The evaluation results are shown in Table 5.
(以下余白)
第五表
更に、第六表に示すように本発明の培養無菌ろ液は長期
にわたる安定性を有している。(The following is a blank space) Table 5 Furthermore, as shown in Table 6, the culture sterile filtrate of the present invention has long-term stability.
(以下余白)
第六表
更に、本発明の培養無菌ろ液の安全性の試験結果を次に
示す。(The following is a blank space) Table 6 Furthermore, the safety test results of the culture sterile filtrate of the present invention are shown below.
粘膜−次刺激性試験
Draize法に従い、体重3.0〜3.5 kgの雌
の白ウサギ9匹を3匹づつ3群に分け、培養無菌ろ液(
A) 0.1−をそれぞれのウサギの片眼結膜のうに
通用し、他眼は対照とした。通用後、−群は無処置のま
ま、他の一群は通用2秒後、更に他の一群は通用4秒後
に微温湯で洗浄し、1 、4.24.48゜72時間及
び4.7日後に観察を行った。角膜、こう彩、結膜とも
に全く刺激性が無かった。Mucosal irritation test According to the Draize method, nine female white rabbits weighing 3.0 to 3.5 kg were divided into three groups of three rabbits each, and cultured sterile filtrate (
A) 0.1- was applied to the conjunctival sac of one eye of each rabbit, and the other eye served as a control. After the application, the - group was left untreated, the other group was washed with lukewarm water 2 seconds after the application, and the other group was washed with lukewarm water 4 seconds after the application. Observations were made. There was no irritation to the cornea, cornea, or conjunctiva.
同様の方法で、培養無菌ろ液(A)の10倍濃縮液、培
養無菌ろ液(B)及びその10倍濃縮液について試験し
たが、全く刺激性は認められなかった。A 10-fold concentrate of the sterile culture filtrate (A), a 10-fold concentrate of the sterile culture filtrate (B), and a 10-fold concentrate thereof were tested in the same manner, but no irritation was observed.
皮膚−次刺激性試験
体重2.0〜2.51qrの白ウサギ8匹を4匹づつ2
群に分け、背部の毛を刈った後、−群はそのまま、他の
一群は被験部分にすり傷をつけ、培養無菌ろ液(A)を
2.50×2.5cIIlのリント布上につけて皮膚に
貼布する。24時間後にリント布をのぞき、観察を行っ
た後、更に48時間、72時間後に再度観察を行った。Skin - secondary irritation test 8 white rabbits weighing 2.0 to 2.51 qr were tested in groups of 4 each.
After dividing the animals into groups and cutting the hair on their backs, the - group left them as they were, and the other group made a scratch on the test area, and applied the culture sterile filtrate (A) on a 2.50 x 2.5 cIIl lint cloth. Apply to the skin. After 24 hours, the lint cloth was removed and observed, and then again after 48 hours and 72 hours.
各群とも、紅斑、施皮の形成及び浮腫とも全く認めるこ
とができなかった。No erythema, skin formation, or edema was observed in any of the groups.
同様の方法で、培養無菌ろ液(A)の10倍濃縮液、培
養無菌ろ液(B)及びその10倍濃縮液について試験を
行ったが、全く刺激性は認められなかった。In the same manner, tests were conducted on a 10-fold concentrated solution of the sterile culture filtrate (A), a 10-fold concentrated solution of the sterile culture filtrate (B), and no irritation was observed.
皮膚感作試験
体重320〜350gの雌のモルモット20匹を10匹
は感作処置用、他の10匹は誘発時の対照としてMax
imization testを実施した。培養無菌ろ
液(A)及びadjuvandを使用して、皮肉注射に
よる感作後、塗布による感作を行い、誘発試験を実施し
たところ肉眼的に変化は認められなかった。Skin sensitization test Out of 20 female guinea pigs weighing 320-350 g, 10 were used for sensitization treatment, and the other 10 were used as controls during induction.
An imization test was conducted. Using the culture sterile filtrate (A) and adjuvand, sensitization was performed by skin injection and then by application, and a provocation test was performed, and no changes were observed macroscopically.
同様の方法で、培養無菌ろ液(A)の10倍濃縮液、培
養無菌ろ液(B)及びその10倍濃縮液について試験を
行ったが、全(感作性は認められなかった。In the same manner, tests were conducted on a 10-fold concentrated solution of the sterile culture filtrate (A), a 10-fold concentrated solution of the sterile culture filtrate (B), and no sensitization was observed.
又同様の方法で、実施例1の(A)のウルトラフィルト
レージョンによる限外ろ退部のる液について試験を実施
したところ、その10倍濃縮液について、10匹中1匹
に僅かに紅斑を認めたが・問題にならない程度であった
。In addition, when a test was conducted using the same method on the liquid from the ultrafiltration section of Ultrafiltration in Example 1 (A), one out of 10 mice showed slight erythema for the 10 times concentrated liquid. However, it was not a problem.
人体パッチ試験
培養無菌ろ液(A)、培養無菌ろ液(B)及びそれぞれ
の10倍濃縮液について、クローズド°パッチテストを
行った。AI−test (IMECOAstra^
gency Co、製)のろ紙部に、それぞれの試料0
.2−をつけ、男子40名の上腕内側に48時間のクロ
ーズド・パッチを行い、1 、24.96時間に判定し
たが、何れも全く陽性を示したものはなかった。Human Patch Test A closed patch test was conducted on the culture sterile filtrate (A), the culture sterile filtrate (B), and their respective 10-fold concentrates. AI-test (IMECOAstra^
Place each sample 0 on the filter paper section of the Gency Co.
.. A closed patch was applied to the inside of the upper arm of 40 men for 48 hours, and the results were evaluated at 1 and 24.96 hours, but none of them showed a positive result.
(発明の効果)
以上、成分分析及び実施例、実験例から明白なように、
本発明の培養ろ液は、アミノ酸、有機酸、可溶性蛋白を
はじめとして、その他機類、無機塩、アルコール等多種
類の吸湿性、保湿性の物質が、既知物質であるか未知物
質であるかを問わず、適度のバランスで効率良く含有さ
れているために、個々の保湿剤を配合してなる従来の化
粧料では得られない優れた効能を有している、安定にし
てかつ安全な化粧料である。ひいては、水分のアンバラ
ンスの結果として生ずる各種の皮膚トラブル、特に肌あ
れ、さめ肌、ヒビ、アカギレ、フケ、カユミ等の予防及
び治療に卓越した効果を有している。更に、本培養ろ液
の有するフルーツエステル芳香は、香りを生命とする化
粧料にとって、優れた性能を付与するものであり、安全
性の面から問題視されている香料の添加を必要とせず、
上記の利点と含まってより優れた化粧料を提供するもの
である。(Effect of the invention) As is clear from the component analysis, examples, and experimental examples above,
The culture filtrate of the present invention contains amino acids, organic acids, soluble proteins, and many other hygroscopic and moisturizing substances such as organic substances, inorganic salts, and alcohol, whether they are known substances or unknown substances. Regardless of the ingredients, it is a stable and safe makeup that has excellent efficacy that cannot be obtained with conventional cosmetics that are formulated with individual moisturizers because it is efficiently contained in an appropriate balance. It is a fee. Furthermore, it has excellent effects on the prevention and treatment of various skin troubles that occur as a result of water imbalance, especially rough skin, flaky skin, cracks, red spots, dandruff, itching, and the like. Furthermore, the fruit ester aroma of the main culture filtrate provides excellent performance for cosmetics that rely on fragrance, and does not require the addition of fragrances, which are considered problematic from a safety perspective.
This product has the above advantages and provides a more excellent cosmetic product.
第一図は、有機酸が自然保湿因子の成分であることを示
すものであり、第二図は可溶性蛋白の分子量分布を示す
ものであり、第三図はエンドミセス属に属する各種の菌
の培養無菌液の水分保持能力を示す図である。
特許出願人 株式会社スギウラ新薬
開発研究所Figure 1 shows that organic acids are components of natural moisturizing factors, Figure 2 shows the molecular weight distribution of soluble proteins, and Figure 3 shows the molecular weight distribution of various bacteria belonging to the genus Endomyces. FIG. 3 is a diagram showing the water retention ability of a sterile culture solution. Patent applicant Sugiura New Drug Development Institute Co., Ltd.
Claims (1)
の培養ろ液を含有することを特徴とする皮膚化粧料。 2 エンドミセス属に属する菌が、エンドミセス・マグ
ヌシ(Endomyces magnusii)である
特許請求の範囲第一項記載の皮膚化粧料。 3 培養ろ液が、分子量13,000以上の高分子物質
を実質的に除去した無菌ろ液である特許請求の範囲第一
項記載の皮膚化粧料。 4 高分子物質を限外ろ過膜で除去する特許請求の範囲
第二項記載の皮膚化粧料。[Scope of Claims] 1. A skin cosmetic containing a culture filtrate of a bacterium belonging to the genus Endomyces. 2. The skin cosmetic according to claim 1, wherein the bacterium belonging to the genus Endomyces is Endomyces magnusii. 3. The skin cosmetic according to claim 1, wherein the culture filtrate is a sterile filtrate from which polymeric substances having a molecular weight of 13,000 or more have been substantially removed. 4. The skin cosmetic according to claim 2, wherein the polymer substance is removed by an ultrafiltration membrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61172450A JPS6327413A (en) | 1986-07-22 | 1986-07-22 | Skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61172450A JPS6327413A (en) | 1986-07-22 | 1986-07-22 | Skin cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6327413A true JPS6327413A (en) | 1988-02-05 |
Family
ID=15942211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61172450A Pending JPS6327413A (en) | 1986-07-22 | 1986-07-22 | Skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6327413A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004010503A (en) * | 2002-06-04 | 2004-01-15 | Ogawa & Co Ltd | Moisture-retaining plant extract and moisture-retaining external preparation containing the extract, cosmetic, bathing agent and detergent composition |
JP2015221756A (en) * | 2014-05-22 | 2015-12-10 | 株式会社コーセー | Yeast culture and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5932119A (en) * | 1982-08-16 | 1984-02-21 | Minoru Yoshida | Surface melting by heat to coil substrate and products thereof |
JPS60164492A (en) * | 1984-02-03 | 1985-08-27 | Ajinomoto Co Inc | Preparation of l-phenylalanine |
JPS6153208A (en) * | 1984-08-21 | 1986-03-17 | Kanebo Ltd | Skin cosmetic |
-
1986
- 1986-07-22 JP JP61172450A patent/JPS6327413A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5932119A (en) * | 1982-08-16 | 1984-02-21 | Minoru Yoshida | Surface melting by heat to coil substrate and products thereof |
JPS60164492A (en) * | 1984-02-03 | 1985-08-27 | Ajinomoto Co Inc | Preparation of l-phenylalanine |
JPS6153208A (en) * | 1984-08-21 | 1986-03-17 | Kanebo Ltd | Skin cosmetic |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004010503A (en) * | 2002-06-04 | 2004-01-15 | Ogawa & Co Ltd | Moisture-retaining plant extract and moisture-retaining external preparation containing the extract, cosmetic, bathing agent and detergent composition |
JP2015221756A (en) * | 2014-05-22 | 2015-12-10 | 株式会社コーセー | Yeast culture and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4099173B2 (en) | Cosmetic or dermopharmaceutical composition comprising kombucha | |
US6562355B1 (en) | Comixture of dextran sulfate/escin for treating skin redness/edema and/or sensitive skin | |
US6468564B1 (en) | Topical compositions containing lotus for skin treatment | |
JP3513873B2 (en) | External preparation for skin | |
WO2002049656A1 (en) | External skin preparations and process for producing the same | |
JPH08231370A (en) | Skin cosmetic | |
JP2001504510A (en) | Pharmaceutical and cosmetic compositions based on microbial cultures mixed with essential oils and acids | |
JP3556595B2 (en) | Cosmetic composition for skin protection containing retinol and epidermal growth factor | |
JP2000044485A (en) | Active oxygen species scavenger and skin cosmetic | |
US20080153741A1 (en) | Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic | |
JPH05186326A (en) | Skin cosmetic | |
JPH0859450A (en) | External preparation for skin | |
CN108653084B (en) | Growth factor-containing skin care composition for men and application thereof | |
EP0024738B1 (en) | Trichosporon kashiwayama ifo 1964, culture liquid, cell-free sterile liquid, sterile filtrate, sterile supernatant, sterile concentrate and sterile dry product of a culture liquid, process for the preparation of a culture liquid, pharmaceutical composition, cosmetic composition | |
KR100440357B1 (en) | Cosmetic compositions containing levan | |
JPH05286843A (en) | Skin cosmetic containing culture mixture of suehirotake @(3754/24)schizophyllum commue) | |
EP0909557A1 (en) | Use of honey as an agent for decreasing micro-organisms adhesion | |
JP3507635B2 (en) | Composition suitable for external use | |
JPH10212225A (en) | Wrinkle preventive | |
JPS6327413A (en) | Skin cosmetic | |
JPH03112912A (en) | Cosmetic composition | |
CN114469817A (en) | Pore-refining composition and preparation method and application thereof | |
JP2002284668A (en) | Preventive and therapeutic agent against darkening | |
JPH06343479A (en) | Thickening agent and its use | |
CN111671703A (en) | Oil-control water-replenishing bidirectional-adjustment essence water |